Amarin | 销售和管理费用



Selling And Administration Expenses 更改 日
AbbVie USD 3.25B 40M 2025-06
Alnylam Pharmaceuticals USD 323.31M 83.36M 2025-06
Amarin USD 36.57M 397K 2025-03
AstraZeneca USD 5.01B 1.42B 2025-06
DBV Technologies USD 4.31M 685K 2025-03
GlaxoSmithKline GBP 2.14B 80M 2025-06
Halozyme Therapeutics USD 33M 9.36M 2025-06
Ionis Pharmaceuticals USD 90.6M 14.6M 2025-06
Neurocrine Biosciences USD 286.3M 9.8M 2025-06
Novartis USD 3.44B 384M 2025-06


Amarin 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Aug 2025.